Do Not Do Recommendation

 
Vinflunine is not recommended within its marketing authorisation for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract that has progressed after treatment with platinum-based chemotherapy

Do Not Do Recommendation Details

Recommendation:
Vinflunine is not recommended within its marketing authorisation for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract that has progressed after treatment with platinum-based chemotherapy
Interventions:
Vinflunine

Source guidance details

Guidance:
Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: guidance (TA272)
Published date:
January 2013
Paragraph number:
1.1
Page number:
3

View all NICE do not do from this Guidance

There are no other recommendations for this guidance.